Cell Source, Inc. (CLCS)
OTCMKTS · Delayed Price · Currency is USD
0.6800
+0.1629 (31.50%)
Sep 8, 2026, 1:28 PM EST
Cell Source Market Cap
Cell Source has a market cap or net worth of $35.13 million as of September 8, 2026. Its market cap has increased by 75.53% in one year.
Market Cap
35.13M
Enterprise Value
45.95M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.68
ChartMarket Cap Chart
Since July 1, 2014, Cell Source's market cap has decreased from 36.03M to 35.13M, a decrease of -2.49%. That is a compound annual growth rate of -0.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 35.13M | 43.93% |
| Dec 31, 2025 | 24.41M | 59.96% |
| Dec 31, 2024 | 15.26M | -14.98% |
| Dec 27, 2023 | 17.95M | -40.09% |
| Dec 29, 2022 | 29.96M | -30.67% |
| Dec 31, 2021 | 43.22M | -32.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NDT Pharmaceuticals | 80.25M |
| Sangamo Therapeutics | 66.70M |
| Nuo Therapeutics | 58.60M |
| Arch Biopartners | 50.27M |
| BetterLife Pharma | 35.87M |
| Vicapsys Life Sciences | 32.37M |
| ProText Mobility | 30.77M |
| Provectus Biopharmaceuticals | 25.22M |